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Voltage-dependent CaV1.2 L-type Ca2 channels (LTCC) are
themain route for calciumentry in vascular smoothmuscle cells
(VSMC). Several studies have also determined the relevant role
of store-operated Ca2 channels (SOCC) in vascular tone regu-
lation. Nevertheless, the role of Orai1- and TRPC1-dependent
SOCC in vascular tone regulation and their possible interaction
with CaV1.2 are still unknown. The current study sought to
characterize the co-activation of SOCC and LTCC upon stimu-
lation by agonists, and to determine the possible crosstalk
between Orai1, TRPC1, and CaV1.2. Aorta rings and isolated
VSMCobtained fromwild type or smoothmuscle-selective con-
ditional CaV1.2 knock-out (CaV1.2KO) mice were used to study
vascular contractility, intracellular Ca2mobilization, and dis-
tribution of ion channels. We found that serotonin (5-HT) or
store depletion with thapsigargin (TG) enhanced intracellular
free Ca2 concentration ([Ca2]i) and stimulated aorta contrac-
tion. These responses were sensitive to LTCC and SOCC inhib-
itors. Also, 5-HT- and TG-induced responses were significantly
attenuated in CaV1.2KO mice. Furthermore, hyperpolarization
induced with cromakalim or valinomycin significantly reduced
both 5-HT and TG responses, whereas these responses were
enhanced with LTCC agonist Bay-K-8644. Interestingly, in situ
proximity ligation assay revealed that CaV1.2 interacts with
Orai1 and TRPC1 in untreated VSMC. These interactions
enhanced significantly after stimulation of cells with 5-HT and
TG. Therefore, these data indicate for the first time a functional
interaction between Orai1, TRPC1, and CaV1.2 channels in
VSMC, confirming that upon agonist stimulation, vessel con-
traction involves Ca2 entry due to co-activation of Orai1- and
TRPC1-dependent SOCC and LTCC.
Vasoactive agonists are known to promote vessel contraction
by a rise in intracellular free Ca2 concentration ([Ca2]i). This
increase in [Ca2]ihas been classically considered to occur first,
due to a rapid Ca2 release from sarcoplasmic reticulum (SR)2
stimulated by inositol 1,4,5-trisphosphate (InsP3), and then to a
transmembrane Ca2 influx through L-type Ca2 channels
(LTCC), especially CaV1.2 channels, which are the main path
for Ca2 entry responsible for the excitation-contraction cou-
pling process in excitable vascular smoothmuscle cells (VSMC)
(1). Other voltage-independent channels are also involved in
transmembrane Ca2 influx, such as store-operated Ca2
channels (SOCC) responsible of extracellular Ca2 entry,
known as store-operated Ca2 entry (SOCE) (2, 3). SOCC have
been characterized both in freshly dispersed and in primary
cultured VSMC from systemic and resistance vessels (4–6). It
is well established that SOCE is mainly due to the activation of
the Ca2-sensing regulatory protein stromal interaction mole-
cule 1 (STIM1) and Orai1, the pore-forming subunit of SOCC
in a wide range of non-excitable cells (7). Additionally, Orai1
was suggested to form a non-Ca2 selective SOCC due to its
association with TRPC1 in excitable cells (8, 9). Interestingly,
evidence showed that TRPC1,Orai1, andCaV1.2might interact
with the proteins of other channels to form a signal complex in
VSMC (10–12).
Taking into consideration that Ca2 enters mainly through
LTCC in VSMC, further understanding of how Orai1 and
TRPC1might influence the role of LTCC in Ca2 signaling and
contractility is needed to explain the physiological role of
SOCC in vessel contraction, which still remains under debate
(13). We hypothesized that Ca2 release from the SR, induced
by a vasoactive agonist such as serotonin (5-HT), could activate
SOCE, leading to depolarization of the VSMC, which would
stimulate LTCC. Therefore, the main aims of this study were
first, to investigate whether SOCC activity might substitute
LTCC function in VSMC, and second, to determine the endog-
enous distribution of Orai1, TRPC1, and CaV1.2 in VSMC.
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Results
Agonist-induced Vasoconstriction Involves Ca2 Entry
through SOCC and LTCC in Endothelium-denuded Mouse
Aorta—The role of SOCCandLTCC in contractile responses of
aorta was studied using 5-HT as vasoactive agonist. Fig. 1A
shows that 5-HT (10 M) evoked a potent vasoconstriction in
endothelium-denuded aorta, which was partially inhibited by
nifedipine (1 M), a specific inhibitor of LTCC in VSMC (14).
The cumulative addition of GSK-7975A (10 M), considered a
specific inhibitor of Orai1 (15), further produced the complete
relaxation of the vessel. Similar effects were also observedwhen
other less specific inhibitors of SOCE, 2APB (50 M) or ML-9
(25 M) (3), were added after nifedipine, as summarized in Fig.
1A. Additionally, pre-treatment of aortic rings with 1 M nife-
dipine attenuated but did not prevent 5-HT responses (Fig. 1, B
and C); meanwhile the supplementary addition of 2APB (50
M) or GSK-7975A (10 M, Fig. 1C) produced the complete
relaxation of the vessel. As shown in Fig. 1B, the addition of
2APB alone (50 M) promoted the full relaxation of 5-HT-in-
duced contraction, in contrast to the effect of nifedipine (Fig.
1A). Interestingly, the specific activation of SOCC with thapsi-
gargin (TG, 10 M), a SERCA inhibitor (16), evoked a nifedip-
ine- (1 M) sensitive vasoconstriction, although the inhibitory
effect of nifedipine was smaller in comparison with its effect on
5-HT responses (Fig. 1D). Further relaxationwas also produced
by the addition of GSK-7975A (10M), 2APB (50M), orML-9
(50 M), indicating that TG-induced vasoconstriction involves
LTCC and SOCC co-activation.
In experiments performed in isolated VSMC, administration
of 5-HT (10 M), applied in the continuous presence of extra-
cellular Ca2, evoked a transient followed by a sustained eleva-
tion of [Ca2]i (Fig. 2A). Both fast and sustained 5-HT-induced
FIGURE 1. Isometric contractions induced by serotonin and thapsigargin in mouse endothelium-denuded aorta. A, representative recording showing
high KCl (70 mM; 70K) and 5-HT (10 M) evoked contractions in endothelium-denuded mouse aorta. The cumulative addition of nifedipine (Nif, 1 M) and
GSK-7975A (GSK, 10 M) fully relaxes 5-HT-induced contraction. GSK-7975A was substituted by 2APB (50 M) or ML-9 (25 M) in other experiments to inhibit
SOCC. The right panel shows a data summary of the effects of Nif (34.08% 4.25; n 16), NifML-9 (7.28% 7.28; n 3), Nif 2APB (0.87% 0.65; n 8),
and NifGSK (0.57% 0.57; n 4) on 5-HT-induced contraction (control; n 17). B, representative traces and data summary showing 5-HT- (10M) induced
contraction in control rings (black bar and trace; 100% 13.01; n 10) and rings pre-treated with 1M Nif for 10min (blue trace and bars; 69.30% 8.45; n
16). 50 M 2APB was added as indicated in control (3.13%  2.40) and in rings pretreated with nifedipine (0.18%  0.13). Values were normalized to 70K
responses. C, data summary showing 5-HT- (10M) induced contraction in rings pre-treatedwith 1Mnifedipine (69.31% 8.45; n 16) and after GSK-7975A
(10 M) administration in rings pretreated with Nif (3.20% 3.20; n 3). D, representative recording and data summary of 10 M TG- (n 20) elicited aorta
contraction. 1MNif (86.05% 3.84; n 22)was added followedbyGSK (0% 0; n 3), 50M 2APB (5.37% 5.37; n 7), or 50MML-9 (21.97% 6.20; n
12). Values are the percentage of mean S.E. *, p 0.05, **, p 0.01 and ***, p 0.001.
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[Ca2]i increases were sensitive to nifedipine (100 nM) and to
the SOCC inhibitors, GSK-7975A (5 M), Gd3 (5 M), 2APB
(25 M), and ML-9 (10 M). Pre-treatment of cells with 2APB
(25 M) together with nifedipine (100 nM) caused significantly
stronger suppression of 5-HT-evoked [Ca2]i responses, as
compared with the effect of nifedipine alone. Similarly, the
addition of TG (2 M) in the presence of extracellular Ca2
induced an increase in [Ca2]i, which was sensitive to nifedip-
ine (100 nM), GSK-7975A (5 M), 2APB (25 M), andML-9 (10
M), as shown in Fig. 2B. The effect of 2APB (25 M) applied
together with nifedipine (100 nM) caused additional reduction
of TG-evoked [Ca2]i increase, like their effects in 5-HT
response. In similar experiments, we tested a higher concentra-
tion of nifedipine (500 nM), and the effects were not signifi-
cantly different from those obtained using 100 nM (data not
shown). Fig. 2C shows data from control experiments in which
Gd3 (5M) and 2APB (50M) did not affect highKCl-induced
[Ca2]i responses. Altogether, these data suggest that 5-HT-
and TG-induced [Ca2]i increase and artery vasoconstriction
involve Ca2 entry through both LTCC and SOCC.
SOCE Does Not Compensate LTCC Function in Endothelium-
denuded Aorta of CaV1.2 Knock-out Mice—Next, we exam-
ined whether SOCC can substitute LTCC function in vascular
tone regulation. We used aorta from a conditional CaV1.2
knock-out (CaV1.2KO) mouse model to assess 5-HT and TG
effects. Fig. 3A indicates that CaV1.2 protein expression was
efficiently decreased in CaV1.2KO mice as compared with wild
type (WT). Consistently, aorta contraction induced by depolar-
izing stimulus, high KCl (70 mM), was significantly attenuated
in CaV1.2KOmice as compared withWT (Fig. 3, B and F). In the
same way, 5-HT (10 M, Fig. 3, C and F) and TG (10 M, Fig. 3,
D and F) induced significantly smaller contractions in
CaV1.2KO aorta as compared with WT. 5-HT- and TG-evoked
vasoconstrictions in CaV1.2KO aorta were still somewhat sensi-
tive to nifedipine (1 M), probably due to the presence of the
remaining functional CaV1.2 channels (Fig. 3, C–H). Interest-
ingly, the evoked contractions were largely inhibited by 2APB
(50 M) or ML-9 (25 M), as shown in Fig. 3, C and D and
summarized in Fig. 3, G and H. Moreover, in freshly isolated
CaV1.2KO VSMC, the addition of high KCl, 5-HT (10 M), or
TG (2 M) evoked significantly reduced [Ca2]i responses, as
compared with WT (Fig. 4, A–C). Because the effect of vaso-
constrictor agonists depends on the initial InsP3-induced Ca2
release from intracellular stores, we checked the integrity of the
SR in CaV1.2KOmice using caffeine, to release Ca2 from ryan-
odine-sensitive stores (17). We observed that vessel contrac-
tions (Fig. 3, E and F) and [Ca2]i increases (Fig. 4, A and C)
induced by caffeine (10 mM) stimulation were not affected in
CaV1.2KO mice, confirming that 5-HT- and TG-reduced
responses are not due to differences in SR Ca2 load between
WT and CaV1.2KO mice.
FIGURE 2. [Ca2]i changes elicited by serotonin and thapsigargin in vascular smoothmuscle cell. A, left panel, representative traces of [Ca
2]i responses
in VSMC presented as fura-2 ratio (F340/F380). High KCl (70 mM; 70K) was applied, and then 5-HT (10M) was added in the presence or absence of inhibitors. In
the right panel, the bar graph summarizes 5-HT-evoked [Ca2]i increases in untreated cells (control, n 486) and cells pre-treated with 100 nM Nif (52.30%
6.20; n  65), 5 M Gd3 (47.15%  12.40; n  48), 25 M 2APB (30.69%  4.40; n  111), 25 M 2APB  100 nM Nif (23.89%  5.00; n  96), 25 M ML-9
(21.67% 0.50; n 102), and 5MGSK (12.67% 6.53; n 160). B, relative data summary of TG- (2M) induced [Ca2]i changes in VSMC (n 379) and in cells
pre-treated with 100 nM Nif (67.51% 9.66; n 141), 25 M 2APB (51.49% 5.45; n 148), 25 M 2APB 100 nM Nif (39.86% 8.89; n 120), 10 M ML-9
(48.70% 7.36; n 110), and 5MGSK (22.10% 13.71; n 152). C, data summary of [Ca2]i increases evoked by 70K in VSMC (100% 7.86; n 85) or in the
presence of 5 M Gd3(105.18% 15.31; n 27) and 50 M 2APB (76.74% 9.15; n 88). Values are the percentage of mean S.E. normalized to the first
response to 70K from at least 3 different experiments. *, p 0.05, **, p 0.01 versus control.
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Effects of Membrane Potential Manipulation on 5-HT and
TGResponses—In light of the previous data demonstrating that
5-HT and TG co-activate SOCC and LTCC, we examined
whether changes in membrane potential are relevant for the
responses to agonists. Therefore, we tested the effect of cro-
makalim, an agonist of ATP-sensitive K channel (KATP)
widely used to promote significant hyperpolarization (18). Fig.
5,A and B, show that aorta pre-treatment with cromakalim (20
M) significantly reduced 5-HT- (10 M) and TG- (10 M)
induced vasoconstriction, whereas pre-treatment of vessels
FIGURE 3. Effect of serotonin in endothelium-denuded aorta isolated fromCaV1.2 knock-outmice. A, Western blots and data summary of CaV1.2 protein
expression inwild type (WT, 1.00 0.10;n 4) andCaV1.2 knock-outmice (CaV1.2
KO, 0.59 0.06;n 4).-Tub,-tubulin. B, representative traces of aortic ring
contractions inducedbyhighKCl (70mM; 70K) in aorta fromWTandCaV1.2
KOmice.C, representative recordings showing5-HT- (10M) evoked contraction and
the effects of the addition of nifedipine (Nif, 1 M) and 2APB (50 M) in aortic rings fromWT and CaV1.2
KO mice. The arrows indicate the time when nifedipine
and 2APB were applied in CaV1.2
KO aortic ring. D, representative traces of TG- (10 M) evoked contraction and the effects of the cumulative addition of
nifedipine (1M) andML-9 (25M) in aortic rings fromWT and CaV1.2
KOmice. E, representative contraction of aortic rings fromWT and CaV1.2
KOmice induced
by caffeine (Caf, 10 mM) F, data summary of aortic ring contractions induced by 70K, 5-HT, TG, and Caf from WT (black bars; 70K, 100% 5.58; 5-HT, 100%
11.23; TG, 100%  10.95; Caf, 100%  12.10; n  11–42) and CaV1.2
KO mice (red bars; 70K, 51.24%  3.17; 5-HT, 46.02%  6.42; TG, 66.23%  10.22; Caf,
71% 18.68; n 10–31).G, data summary of 5-HT-induced contractions fromCaV1.2
KO aorta (n 11) and the effects of 1MNif (64.16% 8.70; n 10), 1M
Nif 50M 2APB (1.34% 0.63; n 6), or 1M Nif 25M ML-9 (5.61% 5.61; n 3). H, data summary showing the effects of 1M Nif (85.14% 4.15; n
12), 1MNif 50M 2APB (0.83% 0.83; n 5), and 1MNif 50MML-9 (4.42% 1.93; n 7) on TG-induced aorta contractions fromCaV1.2
KOmice (n
13). Values are the percentage of mean S.E. *, p 0.05, **, p 0.01, and ***, p 0.001.
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with glibenclamide (3 M), an inhibitor of KATP channel (14)
that blocks the hyperpolarizing action of cromakalim, effi-
ciently antagonized its effects on 5-HT-induced contraction
(Fig. 5A). Moreover, the increase in [Ca2]i induced by both
5-HT (Fig. 5C) and TG (Fig. 5D) in isolated VSMC was also
inhibited by cromakalim (5M). Nevertheless, the responses to
highKCl or caffeine were not significantly affected by the appli-
cation of cromakalim neither in aortic rings (Fig. 5E) nor in
isolated VSMC (Fig. 5F). To confirm these findings, we
explored the effect of valinomycin, a potassium-selective iono-
phore that promotes hyperpolarization, bringing the mem-
brane potential to values close to theNernst potential for potas-
sium (19). As shown in Fig. 6, A and B, pre-treatment of aortic
rings with valinomycin (500 nM) significantly reduced the
effects of 5-HT and TG on vasoconstriction. In addition, incu-
bation of VSMCwith valinomycin (100 nM) significantly inhib-
ited 5-HT- (Fig. 6C) and TG- (Fig. 6D) evoked [Ca2]i increase,
whereas the high KCl and caffeine responses were not affected.
To corroborate the physiological relevance of the co-activa-
tion of LTCC and SOCC during agonist stimulation, we
explored whether LTCC agonist Bay-K-8644 (BayK) (20) could
enhance aorta responses elicited by 5-HT and TG. As shown in
Fig. 7, A and B, aortic rings pre-treated with BayK (100 nM)
exhibited significantly higher contractions when stimulated
with 5-HT and TG as compared with untreated aortic rings.
The addition of 2APB (50 M) efficiently relaxed 5HT- and
TG-induced vasoconstriction in BayK-treated arterial rings.
Similar increased responses were also observed when high KCl
was applied in BayK-treated aorta (Fig. 7C).
Altogether, these data suggest that vasoconstrictions initi-
ated by 5-HT or SOCE activation with TG are attenuated in
hyperpolarized arteries, whereas these responses are potenti-
ated when the LTCC activation threshold is shifted toward
hyperpolarized potentials.
Endogenous Distribution of Orai1, TRPC1, and CaV1.2 in
VSMC—Orai1 and TRPC1 are suggested to interact to form
non-selective SOCC inVSMC (8). Several lines of evidence sug-
gest that the CaV1.2 isoformmight form a different signal com-
plex with other channels to handle [Ca2]i in VSMC (10–12).
Here, we examined the endogenous subcellular localization of
CaV1.2, Orai1, and TRPC1 and their possible interaction by the
in situ proximity ligation assay (PLA). Fig. 8, A and C, show a
large number of PLA red puncta inVSMCwhen incubatedwith
primary antibodies against CaV1.2 and Orai1. Meanwhile, no
PLA signal was detected in VSMC conjugated only with anti-
Orai1 antibody, but without anti-CaV1.2 antibody (Fig. 8, B and
C). Similarly, Fig. 9A shows that CaV1.2 interacts with TRPC1,
as indicated by a large number of red PLA puncta in VSMC.
Interestingly, VSMC stimulation with 5-HT (10 M) and TG (2
M), but not with high KCl, significantly increased puncta sig-
nals, indicating a significant rise in the interaction of CaV1.2
with Orai1 (Fig. 8, A and C) and TRPC1 (Fig. 9, A and C) after
agonist stimulation. These data suggest that Orai1 and TRPC1
interact with CaV1.2 in basal conditions and upon agonist stim-
ulation, which will certainly favor their functional communica-
tion upon agonist stimulation to promote intracellular Ca2
signaling in VSMC.
Discussion
Although it is widely accepted that LTCC and SOCC con-
tribute to the physiopathology of VSMC, their direct functional
relationship had remained virtually unexplored. The present
study provides new data confirming the role of SOCC in vascu-
lar tone regulation, unveiling for the first time a functional
crosstalk between CaV1.2, Orai1, and TRPC1 channels that
might serve for fine-tuning of vascular smooth muscle Ca2
signaling, as summarized in the scheme shown in Fig. 10. Rou-
tinely, to activate SOCE, pharmacological or physiological ago-
nists were added in the absence of Ca2, and then extracellular
Ca2 was restored in the well known “Ca2-free/Ca2-read-
mission” or “Ca2 add-back” protocols (see for example Ref. 5).
Nevertheless, there is little information about physiological
agonists that can activate SOCE in the continuous presence of
extracellular Ca2, without store depletion, as discussed else-
where (13). In this study, we demonstrated that 5-HT applied in
the presence of extracellular Ca2 evoked a fast increase of
[Ca2]i, followed by a sustained phase, in isolated VSMC. 5-HT
also activated a sustained vasoconstriction in aortic rings.
These responses were sensitive to inhibitors of SOCC, support-
ing the involvement of SOCE in vessel contraction. In fact, we
showed that GSK-7975A, which is considered a specific inhib-
itor of Orai1 (15), as well as other blockers, efficiently inhibited
5-HT-induced responses. Gd3, 2APB, and ML-9 are still
widely used as SOCE inhibitors in different cell types (3),
despite their lack of specificity. In this study, the involvement of
SOCC in vasoconstriction is also supported by the specific acti-
vation with TG, which induced aorta vasoconstriction, indicat-
ing that SOCE contributes to vascular tone regulation, in agree-
ment with previous studies (21, 22). Interestingly, we also
FIGURE 4. [Ca2]i increases elicited by serotonin or thapsigargin are
diminished in CaV1.2
KO mice. A, representative [Ca2]i changes in aortic
VSMC fromwild type (WT, black traces) and CaV1.2 knock-out mice (CaV1.2
KO,
red traces) mice evoked by high KCl (70 mM; 70K), 5-HT (10 M), and Caf (10
mM). B, representative [Ca2]i changes of aortic VSMC from WT (black traces)
andCaV1.2
KO (red traces)miceevokedby70KandTG (10M).C, data summary
of [Ca2]i changes induced by 70K, 5-HT, TG, and Caf in VSMC fromWT (black
bars; 70K, 100% 8.77; 5-HT, 100% 13.18; TG, 100% 8.57; Caf, 100%
14.23; n 379–1157) and CaV1.2
KO mice (red bars; 70K, 22.92% 2.82; 5-HT,
20.76% 3.94; TG, 26.83% 6.18; Caf, 99.88% 8.60; n 190–640). Values
are the percentage of mean S.E. ***, p 0.001 versus control.
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demonstrated that SOCC sustained Ca2 entry and vasocon-
striction in CaV1.2KOmice, although not enough to completely
compensate for the absence of functional LTCC. Our results
using the CaV1.2KO mice confirmed the requirement of func-
tional LTCC for vessel contraction even when vasoconstriction
was specifically activated through SOCE using TG. These data
agree with previous studies using CaV1.2KO mice, which dem-
onstrated that CaV1.2 is essential to control blood pressure and
vasoconstrictor responses (17, 23).
Furthermore, increasing lines of evidence suggested that
SOCE activation could serve not only as an important path for
Ca2 entry, but also as a depolarizing trigger for a secondary
activation of LTCC in VSMC (24). Knowing that sarcolemmal
K channels are key regulators of resting potential in VSMC
and vascular tone (25), we demonstrated that 5-HT and TG
responses were sensitive to membrane potential changes, as
they were attenuated by cromakalim or valinomycin, suggest-
ing a smaller contribution of LTCC under these conditions.
Valinomycin is expected to maintain the driving force for Ca2
entry upon SOCE activation, as it impairs membrane depolar-
ization. This might result in a slight increase in Ca2 entry via
SOCE, which, in our hands did not compensate for the effect of
FIGURE 5. Cromakalim attenuates serotonin and thapsigargin responses. A, representative traces and data summary of 5-HT- (10M) evoked contraction
in aortic rings pre-incubated for 15 min with vehicle (control, black trace and bar; 100% 5.73; n 6), with 20 M cromakalim (Crom; blue trace and bar;
44.59% 7.16; n 3) or with 3M glibenclamide together with 20M cromakalim (Gli/Crom, gray trace and bar; 92.47% 0.72; n 3). B, data summary of
TG- (10 M) induced contraction in aortic rings pre-incubated for 15 min with vehicle (control, 100% 9.70; n 4) or 20 M Crom (45.15% 10.86; n 4). C,
representative traces of [Ca2]i changes elicited by high KCl (70 mM, 70K), 10 M 5-HT, and 10 mM Caf in VSMC pre-incubated for 3 min with vehicle (control,
black trace and bar), or with 5M Crom (blue trace and bar). Data summaries of 5-HT responses in the presence of vehicle (control, 100% 14.44; n 79) and
in the presence of Crom (46.39%  10.94; n  87) are shown. D, representative traces of [Ca2]i changes elicited by 70K, 2 M TG, and 10 mM Caf in VSMC
pre-incubated for 3 min with vehicle (control, black trace and bar), or with 5M Crom (blue trace and bar). Data summaries of [Ca2]i changes elicited by 2M
TG applied in control (100%  9.30, n  151) or in the presence of cromakalim (52.36%  2.95, n  94) are shown. E, bar graphs summarize 70K- and
caffeine-induced vasoconstriction in control (70K  100%  4.33 and Caf  100%  6.80; n  6), in rings pretreated for 15 min with 20 M Crom (70K 
90.09%6.39 andCaf80.44%7.68;n3), and in rings treated for 15minwith 3Mglibenclamide20Mcromakalim (Gli/Crom; 70K96.13%5.00;
Caf 84.42% 16.32; n 3). F, data summary of [Ca2]i changes produced by 70K and Caf (10mM) in VSMCpre-treated for 3minwith vehicle (control, 70K
100% 18.67 and Caf 100% 20.13; n 95), or with 5 M Crom (70K 84.97% 22.55 and Caf 80.91% 21.81; n 74). Values are the percentage of
mean S.E. normalized to 70K responses. *, p 0.05, **, p 0.01, and ***, p 0.001.
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the secondary activation of LTCC. To our knowledge, few stud-
ies have suggested that hyperpolarization, due to KCa channel
activation, sustainedCa2 entry through SOCE (for example, in
chondrocytes) (26). On the other hand, BayK, which shifts
LTCC activation to hyperpolarized potentials, enhanced ago-
nist responses. Thus, our results indicated that agonist
responses can be attenuated or potentiated significantly
depending on the open probability of LTCC. Similarly, a recent
study demonstrated that depletion of SR stimulated SOCE,
producing depolarization and LTCC activation in rat myome-
trium (27). Recently, we have determined that the transient
expression of CaV1.2 channel subunits in HEK cells resulted in
a significant increase in Ca2 entry induced by TG, attributed
to secondary activation of CaV1.2 channels induced by cation
influx via SOCC (28). We have also demonstrated that upon
store depletion, STIM1 inhibits Ca2 entry throughLTCC (28),
in agreement with studies by other groups (29). Our data sug-
gest that store depletion might promote two independent
mechanisms involving the interaction of different components
of SOCE with CaV1.2 to fine-tune its activity: Ca2 influx via
SOCE promotes secondary activation of LTCC, and STIM1
modulates CaV1.2 function. Certainly, further investigations
are needed to shed more light on this intriguing reciprocal reg-
ulation of LTCC by store depletion. In fact, the dual regulation
of LTCC by [Ca2]i increase has been extensively studied in
excitable cells, as reviewed recently (30). [Ca2]i enhancement
is known to promote the well characterized Ca2-dependent
inactivation process likely to prevent Ca2 overload (31),
whereas [Ca2]i increase can also stimulate Ca2-dependent
facilitation of CaV1.2 to potentiate Ca2 influx, for example,
during the excitation-contraction coupling in VSMC (32).
Another important issue that remains under debate is the
identity of SOCC in excitable VSMC. Several groups have
FIGURE 6. Valinomycin attenuates serotonin- and thapsigargin-induced vasoconstriction and [Ca2]i increase. A and B, representative traces and data
summary of 5-HT- (10M) and TG- (10M) evoked contractions in control aortic rings (inblack; 5-HT 100% 10.62,n 9; and TG 100% 16.07;n 5), and in
ringspre-incubated for 15minwith500nMvalinomycin (Val, inblue; 5-HT35.10%4.67,n4andTG5.57%0.53,n3).CandD, representative traces and
datasummaryof [Ca2]ichangeselicitedbyhighKCl (70K, 70mM)10M5-HT,and2MTGandincontrolVSMC(5-HT100%11.24,n93andTG100%12.64,
n90)and incellspre-incubated for3minwith100nMvalinomycin (5-HT3.68%0.63,n89andTG6.38%1.95,n114). 10mMCafwasappliedat theend
of each experiment as indicated. Values are the percentage ofmean S.E. normalized to 70K responses. **, p 0.01.
FIGURE 7. LTCC agonist, BayK, increases endothelium-denuded aorta
responses.A and B, representative traces and data summary of 5-HT- (10M)
and TG- (10 M) evoked contractions in control aortic rings (in black; 5-HT
100%  10.53, n  3; and TG  100%  17.57, n  6) and in rings pre-
incubated for 15 min with 100 nM BayK (in blue; 5-HT 131.30% 7.16, n
4 and TG 155% 13.65, n 5). 2APB (50M)was added as indicated.C, bar
graph shows a data summary of high KCl (70K, 70 mM) responses in control
rings (100% 1.55, n 11) and in rings pre-incubated with BayK for 15 min
(110% 1.83, n 12). Values are the percentage of mean S.E. normalized
to 70K responses. *, p 0.05, ***, p 0.001.
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shown interactions between different proteins to form the
SOCE signaling complex as discussed elsewhere (33, 34). Here,
using in situPLA assay, we showed for the first time that endog-
enous Orai1, TRPC1, and CaV1.2 are distributed in close vicin-
ity. Indeed, hybridization of the PLA probes that occurs when
proteins are40 nm apart (35) confirmed a strong co-localiza-
tion between these channels. Remarkably, we observed a signif-
icant increase of puncta signals in cells incubated with agonists
that involve SOCEactivation (5-HT through the InsP3 signaling
pathway and TG via SERCA inhibition), but not with depolar-
izing stimulus with high KCl. These data suggest that agonist-
induced Ca2 influx is likely due to a functional interaction/
communication between TRPC1- andOrai1-dependent SOCC
and CaV1.2 channels in VSMC. Recently, independent studies
showed that Orai1 associates with other channels to form the
arachidonate-regulated Ca2 (ARC) channels (36), associates
with TRPC1 to form non-selective SOCC (8, 37), or even asso-
ciates with small conductance Ca2-activated potassium chan-
nel 3 (SK3) (11). Therefore, we provided several lines of evi-
dence demonstrating that the SOCC components, Orai1 and
TRPC1, form amacromolecular complex with CaV1.2 LTCC to
regulate [Ca2]i signaling and vascular tone.
Experimental Procedures
Ethical Approval—All experiments were conducted in
accordance with the Spanish legislation on protection of ani-
mals (Royal Decree 53/2013), conformed to the Directive 2010/
63/EU of the European Parliament, and were approved by the
local Ethics Committee of Animal Care of the University Hos-
pital Virgen del Rocío (HUVR) of Seville.Mice (strainC57BL/6)
were sacrificed by intraperitoneal administration of a lethal
dose of sodium thiopental (200 mg/kg).
CaV1.2KO Mouse Model—We used WT and CaV1.2KO mice
generated at the Institut für Pharmakologie und Toxikologie,
München, Germany (17, 23). CaV1.2KO mice express a tamox-
ifen-inducible Cre recombinase under control of the SM22
promoter (SM-Cre ERT2(ki)). To induce smooth muscle-spe-
cific Cre recombination, adult mice were treated with freshly
prepared tamoxifen solution dissolved in corn oil at 10 mg/ml
(Sigma) by intraperitoneal injection once a day for 5 days at a
dosage of 1 mg/day. CaV1.2KO mice were analyzed between 16
and 18 days after the first injection of tamoxifen, as these ani-
mals die between 18 and 21 days (23). The background mouse
strain was C57BL/6.
FIGURE 8.Orai1 and CaV1.2 co-localization in aortic myocytes. A, representative images of aortic VSMC using primary antibodies against CaV1.2 and Orai1
conjugated with the appropriate PLA probes, from untreated control cells or from cells stimulated with 5-HT (10 M), TG (2 M), or high KCl (70K, 70 mM). Red
puncta indicate thatproteins are in closeproximity (40nm). The left panels showVSMC imageswhenantibodieswere conjugatedwithPLAprobes, themiddle
panels show merges images from cells also stained with DAPI (blue), and the right panels show bright field (BF) pictures. B, images from VSMC using primary
antibodies against -SMA and vimentin used as positive control (upper panel) and from VSMC conjugated with only anti-Orai1 primary antibody as negative
control (lower panel). C, the bar graph summarizes themean number of PLA signals in untreated control VSMC (15.42% 1.50; n 6), and in VSMC stimulated
with 5-HT (21.60% 1.65; n 10), TG (28.90% 3.81; n 8), or 70K (18.33% 2.45; n 8). No detectable PLA puncta were observed in control experiments
using cells conjugated only with anti-Orai1 antibody (Orai1, n 8). The interaction between anti--SMA and anti-vimentin antibodies was used as positive
control (100%  25.88; n  5). Similar experiments were repeated 3 times. Values are the percentage of mean  S.E., normalized to positive control.
Significance values indicate difference as compared with control, *, p 0.05.
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Measurement of Contractility in Arterial Rings—Thoracic
aorta was quickly removed and placed in ice-cold Krebs solu-
tion (in mM: 118.5 NaCl, 4.7 KCl, 2.5 CaCl2, 24.8 NaHCO3, 1.2
MgSO4, 1.2KH2PO4, 10 glucose). Then, aortawas cleaned from
connective tissue, cut in rings (2 mm), and mounted on a
small-vesselmyograph (J.P.Trading,Aarhus,Denmark) tomea-
sure isometric tension connected to a digital recorder (Myo-
dataq-2.01, Myodata-2.02 Multi-Myograph System) as de-
scribed previously (5). Aorta rings were placed on a chamber
filled with Krebs solution at 37 °C bubbled with 95%O2 and 5%
CO2. Before the experiments, segments were subjected to a
basal tension of 2.5micronewtons and stabilized for at least 1 h.
The endothelium was mechanically removed by rubbing the
luminal surface of the ring with a small plastic tube, and the
integrity of the endotheliumwas tested at the beginning of each
experiment by the addition of acetylcholine (up to 10 M) as
described previously (38). The data summary presented in bar
graphs shows normalized responses of the increment and the
difference between the maximum contraction and resting tone
of the vasoconstriction.
Preparation of Aortic Smooth Muscle Cells—The segment of
thoracic aorta was quickly removed and placed in cold physio-
logical solution (PS) (in mM: 137 NaCl, 5.4 KCl, 0.2 CaCl2, 4.17
NaHCO3, 2 MgCl2, 0.44 KH2PO4, 0.42 NaH2PO4, 10 HEPES,
11.11 glucose, 0.05 EGTA). Aorta was dissected, cleaned, cut
into pieces, and incubated with 1–2 mg/ml elastase (4 units/
mg) and 4 mg/ml collagenase type I (125 units/mg) (Sigma) in
PS for 1 h at 4 °C and then for 10–15 min at 37 °C. Cells were
mechanically dispersed using fire-polished glass pipettes and
plated on coverslips. VSMC were easily distinguished by their
size and typical elongated shape, and samples from dispersed
cells were stained withmouse anti--SMA antibody (Sigma) or
phalloidin (Sigma), amarker for F-actin, to verify preparation of
VSMC and to rule out any major presence of fibroblasts or
endothelial cells.
Cytosolic Ca2 Measurement—VSMC plated on coverslips
were incubated in PS with 2–5 M Fura-2AM for 30 min at
room temperature, and then cells were washed. For the exper-
iments, a coverslip was placed on the stage of Nikon Eclipse
TS-100 inverted microscope equipped with a 20 Fluor objec-
tive (0.75NA), as described previously (5). Fluorescence images
from a large number of loaded single cells were recorded and
analyzed with a digital fluorescence imaging system (InCyt
Basic Im2, Image Solutions (UK) Ltd., Preston, UK) equipped
FIGURE 9.TRPC1andCaV1.2 co-localization in aorticmyocytes.A, representative images of aortic VSMCusingprimary antibodies against CaV1.2 and TRPC1
conjugated with the appropriate PLA probes, from untreated control cells or from cells stimulated with 5-HT (10 M), TG (2 M), or high KCl (70K, 70 mM). Red
puncta indicate thatproteins are in closeproximity (40nm). The left panels showVSMC imageswhenantibodieswere conjugatedwithPLAprobes, themiddle
panels show merge images from cells also stained with DAPI (blue), and the right panels show bright field (BF) pictures. B, images from VSMC using primary
antibodies against -SMA and vimentin used as positive control (upper panel) and from VSMC conjugated with only anti-TRPC1 primary antibody as negative
control (lower panel). C, the bar graph summarizes themean number of PLA signals in control VSMC (9.85% 1.53; n 9), and in 5-HT- (19.98% 4.72; n 8),
TG- (35.53% 8.78;n 9), or 70K- (7.72% 2.76;n 4) treatedVSMC.Nodetectable PLApunctawere observed in control experiments using cells conjugated
onlywith anti-TRPC1 antibody (TRPC1, n 10). The interaction between anti--SMA and anti-vimentin antibodieswas used as positive control (100% 14.63;
n  7). Similar experiments were repeated 3 times. Values are the percentage of mean  S.E., normalized to positive control. Significance values indicate
difference as compared with control, *, p 0.05, ***, p 0.001.
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with a light-sensitive CCD camera (Cooke PixelFly, Applied
Scientific Instrumentation, Eugene, OR). Changes in [Ca2]i
are represented as the ratio of Fura-2 fluorescence induced at
an emission wavelength of 510 nm due to excitation at 340 and
380 nm (ratio  F340/F380). Ca2 influx was calculated as the
difference between the peak ratio before and after the addition
of different drugs (ratio). Data summaries are normalized to
control values obtained in each cell preparation as indicated in
the figure legends. Auto-fluorescence was determined at the
end of each experiment by the addition of ionomycin and
MnCl2. Experiments were performed using a continuous per-
fusion system in physiological salt solution (in mM, pH  7.4:
140 NaCl, 2.5 CaCl2, 2.7 KCl, 1 MgCl2, 10 HEPES, 10 Glucose).
High KCl solution was also used (in mM, pH 7.4: 70 NaCl, 2.5
CaCl2, 70 KCl, 1 MgCl2, 10 HEPES, 10 glucose).
Protein Extraction and Western Blotting—Dissected arteries
frommicewere flash-frozen in an ice-coldmixture of 10%TCA
and 10 mM DTT in acetone. Arteries were later washed in ice-
cold acetone containing 10mMDTT and lyophilized overnight.
Prior to protein extraction, the lyophilized vessels were
weighted in an ultra-precision scale to normalize the Western
blotting load. 1 l of sample buffer (60 mM Tris HCl, pH 6.8,
10% glycerol, 2% SDS, 0.01% bromphenol blue, 100 mM DTT)
was added for each 2 g of artery for protein extraction. Sam-
ples were heated at 95 °C for 10 min and rotated overnight at
4 °C prior to electrophoresis. Similar amounts of protein sam-
ples extracted fromWT and CaV1.2KO mice were subjected to
SDS-PAGE (10%) and electro-transferred onto nitrocellulose
membranes. After blocking with 5% nonfat dry milk dis-
solved in Tris-buffered saline containing 0.1% Tween 20
(TTBS) for 2 h at room temperature, Western blots were
probed overnight at 4 °C or for 1.5 h at room temperature
with specific primary antibodies in blocking solution. After
washing, membranes were incubated for 1 h at room tem-
perature with a horseradish peroxidase-conjugated anti-rab-
bit or anti-mouse IgG (Jackson ImmunoResearch Laborato-
ries) in TTBS. Detection was performed with the enhanced
chemiluminescence reagent ECL Plus (Amersham Biosci-
ences) and the ImageQuant LAS 4000 Mini Gold system.
Primary antibodies used were: rabbit anti-CaV1.2 (1:200,
Alomone Labs) and mouse anti--tubulin (1:5000, Sigma) as
housekeeping loading control. For quantification, tiff images
were analyzed with ImageJ software.
In Situ Proximity Ligation Assay—Spatial co-localization of
CaV1.2 andOrai1were analyzedwith PLA technology in freshly
isolated aortic myocytes using the Duolink in situ PLA detec-
tion kit Red (Sigma), following themanufacturer’s instructions.
VSMC were seeded in a six-channel -Slide from IBIDI and
fixed with 100% cold methanol for 5 min. VSMC were blocked
for 30 min with 3% heat-inactivated goat serum and 1% BSA in
PBS and incubated with primary antibodies (rabbit anti-
CaV1.2, 1:50 (Alomone Labs); mouse anti-Orai1, 1:100 (Novus
Biologicals); or mouse anti-TRPC1 1:50 in blocking solution
(Santa Cruz Biotechnology)) for 2 h at room temperature. Cells
were labeled with Duolink PLA anti-rabbit PLUS and anti-
mouseMINUS probes for 1 h at 37 °C. The secondary antibod-
FIGURE 10. Schematicmodel summarizingOrai1, TRPC1, andCaV1.2 co-activationupon5-HT stimulation.Wepropose that 5-HT binding to its receptors
promotes InsP3-induced Ca
2 release, depletion of Ca2 stores, activation of Ca2 entry through Orai1, and TRPC1-dependent SOCC. The consequent SOCE
will trigger secondary activation of LTCC, allowing a significant increase in intracellular free Ca2 concentration and further aorta contraction.
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ies of PLA PLUS andMINUS probes were attached to synthetic
oligonucleotides that hybridize when they are in close proxim-
ity (i.e. 40 nm separation). The hybridized oligonucleotides
were then ligated for 30 min at 37 °C prior to rolling circle
amplification for 100 min at 37 °C. Fluorescently labeled oligo-
nucleotides hybridized to the rolling circle amplification prod-
uct. The red fluorescent fluorophore-tagged oligonucleo-
tides were visualized using a confocal microscope (Leica
TCS SP2). Maximum intensity projections of all z-sections
(0.5 m) were obtained by ImageJ software, and puncta of
maximum intensity projections were analyzed by Duolink
ImageTool software (Sigma). The interaction between anti-
-SMA and anti-vimentin antibodies was used as positive
control (Fig. 8B). As a negative control, we conducted exper-
iments using only one primary antibody (mouse anti-Orai1
or anti-TRPC1 antibodies), which did not show any detect-
able PLA signal (Fig. 8C).
Confocal Acquisition—Direct confocal acquisition of fluores-
cencewas performed using a Leica TCS SP2microscope (Leica)
equipped with a blue diode at 405 nm, argon-krypton at 458–
514 nm, helium-neon at 543 nm, and helium-neon at 633 nm.
Images were acquired using a HCX Pl Apo CS 63/1.3 immer-
sion objective in z-stack intervals of 0.5 m. Confocal acquisi-
tion of fluorescence labels was performed as follows: DAPI
(excited at 405 nm and recorded on 400–450 nm) and Alexa
Fluor 594 (excited at 594 nm and recorded at 593–667 nm). All
figures were processed and mounted by ImageJ software (Con-
focalUniovi 1.5 ImageJ), and image deconvolution was con-
ducted using an ImageJ plugin for spectral image deblurring
(Parallel Spectral Deconvolution) based on a generalized Tik-
honov regularization method (39).
Drugs—Drugs were purchased from Sigma, Invitrogen, and
Aobious. The concentration of some inhibitors tested in this
study variedwhen theywere used in vessels or cells, but all were
within the range of their optimum effects. Higher concentra-
tions were used in rings to ensure inhibitor permeability in
thick aorta.
Statistical Analysis—Data analysis was carried out using
SigmaPlot software, version 11.0. A sample size calculation was
performed prior to the start of this study.We expected a decrease
of50–100% in vasoreactivity usingCaV1.2KOmice.We decided
to include at least 3–5 subjects for each experiment, taking into
consideration an  of 5% and power of 90% or an  of 1% and
power of 80% and keeping in mind the failed experiments. Statis-
tical analyses were performed by Student’s t test for two-group
comparison or one-way analysis of variance followed by Tukey
multiple comparison post hoc tests comparing different groups.
Group data are presented as the percentage of mean S.E. and p
values 0.05,0.01, and0.001 were considered significant as
indicated in the figures with *, **, and ***, respectively.
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